Explore evidence

Gold tier: mechanically validated evidence, with its primary source.

134 evidence items · page 5 / 6

43 %In this study, the G1764A mutation in the BCP region was found in 18 out of 42 (43%) asymptomatic carriers.

Nigeriahépatite Bpublished 2025Viruseseurope_pmcdocument of 6 observations

2.7 %The prevalence of HBeAg among 150 PLHIV in the study was 2.7%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

The low frequency of individuals vaccinated against HBV suggests a need for improved vaccination services.

Nigeriahépatite Bpublished 2022Journal of immunoassay & immunochemistryPubMeddocument of 5 observations

8.3 %HBV was detected in 8.3% of 400 blood donors at the Federal Medical Center in Azare.

Nigeriahépatite Bpublished 2025BMC infectious diseasesPubMeddocument of 5 observations

18.7 %Twenty-eight (18.7%) of 150 PLHIV had at least one serological marker of hepatitis B virus.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

16.1 %HBsAg prevalence among 310 HIV-positive individuals in Southwestern Nigeria was 16.1% (50/310).

Nigeriahépatite B · VIH/sidaobserved June 2017 to August 2017published 2021Virology journalPubMeddocument of 6 observations

100 %Hepatitis B screening was performed in all 31 hospitals (100%).

Nigeriahépatite Bobserved 2014published 2016International healtheurope_pmcdocument of 11 observations

6.9 %Hepatitis B surface antigen (HBsAg) prevalence was 6.9% among 248 patients at the Federal Medical Center, Makurdi.

Nigeriahépatite Bpublished 2024BMC public healthPubMeddocument of 7 observations

3.22 %Among HIV-positive patients aged 21–30 years in the study, the prevalence of HIV/HBV co-infection was 3.22%.

Nigeriahépatite B · VIH/sidaobserved 2019published 2020Journal of immunoassay & immunochemistryPubMeddocument of 9 observations

6.2 %The seroprevalence rate for hepatitis B virus among blood donors at the Lagos University Teaching Hospital in Nigeria was 6.2% over the 2015–2019 period.

Nigeriahépatite Bobserved 2015-2019published 2022British journal of haematologyPubMeddocument of 7 observations

10.4 %The highest HBV prevalence in Nigeria was 10.4% in the north-central geopolitical zone.

Nigeriahépatite Bobserved 2018published 2025Pathogens (Basel, Switzerland)PubMeddocument of 8 observations

11.8 %The proportion with HBV was 11.8% among those with tattoo/body incision.

Nigeriahépatite Bpublished 2022Journal of immunoassay & immunochemistryeurope_pmcdocument of 5 observations

15 %The frequency of HBeAg among HBV mono-infected cohort was 15%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 11 observations

1.1 %The prevalence of HIV-hepatitis B-hepatitis C triple infection among people living with HIV/AIDS in a rural Northern Nigerian community was 1.1%.

Nigeriahépatite B · hépatite C · VIH/sidapublished 2020The Pan African medical journalPubMeddocument of 4 observations

14.8 %Among PLHIV aged 31–40 years, the prevalence of anti-HBs was 14.8%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

3.5 %The prevalence of hepatitis B surface antigenemia among HIV positive patients on anti-retroviral treatment programme in Anyigba, Kogi State, North-Central Nigeria was 3.5%.

Nigeriahépatite B · VIH/sidapublished 2019African health sciencesPubMed

7.3 %The proportion with HBV was 7.3% among those with history of sharing of sharp objects.

Nigeriahépatite Bpublished 2022Journal of immunoassay & immunochemistryeurope_pmcdocument of 5 observations

2.49 adjusted_odds_ratioThe absence of HBV vaccination was independently associated with HBV infection in pregnancy, with an adjusted odds ratio of 2.49.

Nigeriahépatite Bobserved November 1, 2017 to April 30, 2018published 2020Annals of African medicinePubMeddocument of 5 observations

10.9 %Among 265 livestock handlers in Ibadan, Nigeria, 29 (10.9%) tested positive for HBV infection.

Nigeriahépatite Bobserved October 2016 to April 2017published 2024African health sciencesPubMeddocument of 5 observations

33 %In this study, the A1762T mutation in the BCP region was found in 14 out of 42 (33%) asymptomatic carriers.

Nigeriahépatite Bpublished 2025Viruseseurope_pmcdocument of 6 observations

1.9 adjusted_odds_ratioHIV co-infection was independently associated with HBV infection in pregnancy, with an adjusted odds ratio of 1.90.

Nigeriahépatite B · VIH/sidaobserved November 1, 2017 to April 30, 2018published 2020Annals of African medicinePubMeddocument of 5 observations

12.8 %The classical PC mutant variant G1899A was observed in 12.8% of sequenced BCP/PC gene amplicons.

Nigeriahépatite Bpublished 2023Viruseseurope_pmcdocument of 6 observationsDOI 10.3390/v15112188

49.9 unitless_ratioPWR for HBV negative participants was 49.9 ± 28.6, higher than that for HBV positive participants (41.4 ± 17.6).

Nigeriahépatite Bpublished 2021West African journal of medicineeurope_pmcdocument of 4 observations

6.1 %Among female PLHIV participants, the prevalence of anti-HBe was 6.1%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

0.4 %Among 265 livestock handlers in Ibadan, Nigeria, 1 (0.4%) was coinfected with HBV and HCV.

Nigeriahépatite B · hépatite Cobserved October 2016 to April 2017published 2024African health sciencesPubMeddocument of 5 observations

Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.